TNXP — Tonix Pharmaceuticals Holding Share News
0.000.00%
Last trade - 00:00- $88.67m
- -$87.56m
- $13.11m
Brief: Tonix Pharmaceuticals - Amends Sales Agreement With Alliance Global Partners - SEC Filing
Brief: Tonix Pharmaceuticals - Increases Share Repurchase Program To $35 Million - SEC Filing
U.S. STOCKS ON THE MOVE-TransAlta, Johnson & Johnson, E.W. Scripps
U.S. STOCKS ON THE MOVE-Sunoco, Albemarle, GE Healthcare Technologies
Tonix set for best day in over two months as new fibromyalgia drug hits U.S. market
Tonix rises as first new fibromyalgia drug in 15 years becomes available in U.S.
Tonix Pharmaceuticals Q3 net loss widens
Brief: Tonix, Mass General Partner on Phase 2 Trial of TNX-1500 to Prevent Kidney Transplant Organ Rejection
Brief: Tonix Pharmaceuticals - Prelim Q3 Net Revenue From Product Sales $3.3 Million - SEC Filing
Brief: Tonix Pharmaceuticals Plans To Initiate Prader-Willi Syndrome Phase 2 Trial Of Tnx-2900 In 2026
Brief: Tonix Reports Positive Pre-IND FDA Meeting for TNX-102 SL in Major Depressive Disorder Treatment
Brief: Tonix Pharmaceuticals Announces In-Licensing Phase 2/3-Ready Monoclonal Antibody Designed For Seasonal Prevention Of Lyme Disease (Tnx-4800)
U.S. STOCKS ON THE MOVE-Soho House, Cogent Communications, Beyond
U.S. STOCKS ON THE MOVE-Soligenix, BioXcel, GoodRx
Tonix sees inflection in sales of non-opioid pain drug after mid-2026, shares fall
U.S. STOCKS ON THE MOVE-CVS Health, TeraWulf, Yext
U.S. STOCKS ON THE MOVE-US solar stocks, Dayforce, Duolingo
Tonix Pharma rises after US FDA approves fibromyalgia drug
Tonix Pharmaceuticals surges after FDA nod for non-opioid pain drug